No independent research group has conducted a properly powered, double-blind, placebo-controlled trial of topical GHK-Cu for skin aging
Aparicio T, Cozic N, de la Fouchardire C, Meriaux E, Plaza J, Mineur L
Extrapolating mecasermin data to IGF-1 LR3 is problematic because the pharmacokinetics and tissue exposure profiles differ significantly due to the binding protein modifications
Do GLP-1s and GIPs work the same way for everyone, or can results vary from person to person
But even though Humira, which was first FDA-approved in 2002 for treating rheumatoid arthritis, can provide significant symptom relief, many patients who take it complain that it burns upon injection
Science FAQ 1